Summary : As part of India’s efforts to showcase the country’s investment-friendly policies and growth opportunities in agriculture and allied sectors at…
ChemRobotics Pvt. Ltd. © 2023, All Rights Reserved.
Designed and Developed by Ample eBusiness
Tag:
Drug Delivery
-
-
Agro Science & ResearchIndia
Yes Bank launches start-up enabler programme for food and agri sector
by adminby adminSummary : Private sector lender Yes Bank has launched a programme for digital financing solutions in the food and agriculture sector under…
-
Pharma Science & Research
New study reveals cataract surgery may reduce dementia risk in older patients
by adminby adminSummary : The overall risk for dementia was 29 per cent lower in those who had cataract surgery compared with those who…
-
Synopsis : Tesla Inc changed an advertisement about the driving range for its Model 3 in South Korea after an antitrust regulator…
-
BioNTechGlobal Market
BioNTech introduces first modular mRNA manufacturing facility to promote scalable vaccine production in Africa
by adminby adminSummary : BioNTech SE (Nasdaq: BNTX, “BioNTech”) has taken a next step to improve vaccine supply in Africa. The company has introduced…
-
Although fractures normally heal, bone will not regenerate under several circumstances. When bone does not regenerate, major clinical problems could result, including…
-
Summary : FabiSpray will be marketed at a price of Rs 850 per unit. The recommended dosage for treatment of mild Covid-19…
-
Synopsis : Star Therapeutics has exited stealth mode and announced a spin-off company, Electra Therapeutics. Electra received $84 million in Series B…
-
Global Market
Western Potash Holdings Corp. and Vantage Chance Limited Enter Into Subscription Agreement
by adminby adminSummary : Western Resources Corp. is pleased to announce that it has signed a subscription agreement (the “Subscription Agreement”) today with Vantage…
-
Pharma Science & Research
Marker Therapeutics Announces Clinical Program Updates and Pipeline Expansion
by adminby adminSummary : -Results from safety lead-in stage of Marker’s Phase 2 AML trial demonstrate that MT-401 was well-tolerated, eliminated measurable residual disease…